PL EN


Preferences help
enabled [disable] Abstract
Number of results
2019 | 119 | 224-230
Article title

Antimycobacterial activity of ethanolic extract of Artemisia absinthium L.

Content
Title variants
Languages of publication
EN
Abstracts
EN
It is known that, drugs used in the treatment of tuberculosis show toxic effect to organism especially to liver beside its therapeutic effect. Because of ineffectiveness of drugs used in the treatment regimen of tuberculosis against multidrug resistance (MDR) and extensively drug-resistance (XDR) tuberculosis requires the development of new treatment methods and new novel drugs. Considering the usage of Artemisia absinthium in traditional medicine in treatment of wounds which suggests its antibacterial activity it seems that, also it may have significant antimycobacterial activity. The objective of present study was to evaluate antibacterial activity of ethanolic extract of A. absinthium against M. tuberculosis. In this study, the effect of ethanolic extract of A. absinthium was tested against tuberculosis and pharmaco-toxicological properties evaluated on laboratory animals. The 20%, 40%, 70% and 96% ethanolic extracts of A. absinthium prepared then its bacteriostatic and bactericidal activities were evaluated by validated methods. Data were analyzed by GraphPad Prism 7.0 at the level P<0.05. Results showed that ethanolic extracts of A. absinthium show no toxicological properties with having high LD50. All concentrations of extract show high bacteriostatic activity on M. tuberculosis. 96% ethanolic extract has highest bactericidal effect among other concentrations. By conducting further studies, as a results of our study, antimycobacterial drug can be prepared from A. absinthium.
Discipline
Year
Volume
119
Pages
224-230
Physical description
Contributors
  • State Medical University of Turkmenistan, Ashgabat, Turkmenistan
  • State Medical University of Turkmenistan, Ashgabat, Turkmenistan
  • Velayat Tuberculosis Hospital of Balkan velayat, Balkan, Turkmenistan
References
  • [1] WHO. Global tuberculosis report, 2018.
  • [2] Gandhi NR, Nunn P, Dheda K, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. The Lancet Volume 375, ISSUE 9728, P1830-1843, May 22, 2010. DOI:10.1016/S0140-6736(10)60410-2
  • [3] Niederweis M, Danilchanka O, Huff J, Hoffmann C, Engelhardt H (2010). Mycobacterial outer membranes: in search of proteins. Trends in Microbiology 18 (3): 109–16. doi:10.1016/j.tim.2009.12.005.
  • [4] Marrakchi H, Lanéelle MA, et al. Mycolic acids: structures, biosynthesis, and beyond. Chem Biol. 2014 Jan 16; 21(1): 67-85. doi: 10.1016/j.chembiol.2013.11.011.
  • [5] Kumar R., Bhatia V., Khanal S. Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome. Hepatology 2010; 51: 1665–1674.
  • [6] Devarbhavi H., Dierkhising R., Kremers W.K. Antituberculosis therapy drug-induced liver injury and acute liver failure. Hepatology 2010; 52: 798–799. author reply 799–800. doi: 10.1002/hep.23805
  • [7] Zumla AI, Gillespie SH, Hoelscher M, et al. New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects. Lancet Infect Dis. 2014; 14(4): 327–40. 10.1016/S1473-3099(13)70328-1.
  • [8] Forget EJ, Menzies D. Adverse reactions to first-line antituberculosis drugs. Expert Opin Drug Saf. 2006 Mar; 5(2): 231-49.
  • [9] B.E. Gulbay et al., Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis. Respir Med. 2006 Oct; 100(10): 1834-42.
  • [10] Hamburger, M. and Hostettmann, K. (1991). Bioactivity in plants: the link between phytochemistry and medicine. Phytochemistry 30: 3864-3874.
  • [11] Singh, P. and Singh, C. L. (1981). Chemical investigations of Clerodendraon fragrans. Journal of Indian Chemical Society 58: 626-627.
  • [12] Nguta, J.M., Regina, A.O., Nyarko, A.K., Manu, D.Y., Addo, P.G.A., (2015). Current perspectives in drug discovery against tuberculosis from natural products. Int. J. Mycobacteriol. 4, 165–183.
  • [13] Juteau F, Jerkovic I, Masotti V, Milos M, Mastelic J, et al. (2003) Composition and Antimicrobial Activity of the Essential Oil of Artemisia absinthium from Croatia and France. Planta Med 69: 158–161.
  • [14] Priscila IU, Mariama TNS, Luiz CDS, Luciano B, Fernandes AJ: Antibacterial activity of medicinal plant extracts. Braz J Microbiol. 2007, 38: 717-719.
  • [15] Rustaiyan A, Masoudi S (2011). Chemical composition and biological activities of Iranian Artemisia species. Phytochem. Lett. 4: 440-447.
  • [16] Thomsen M (2005). Phytotherapy Desk Reference. 3rd Edition. Michael Thomsen.
  • [17] Fiamegos YC, Kastritis PL, Exarchou V, Han H, Bonvin AMJJ, Vervoort J, Lewis K, Hamblin MR, Tegos GP (2011). Antimicrobial and Efflux Pump Inhibitory Activity of Caffeoylquinic Acids from Artemisia absinthium against gram-positive pathogenic bacteria. PLOS ONE 6(4): e18127. DOI:10.1371/journal.pone.0018127
  • [18] Reinke R, King PJ, Victoria GJ, McDougall RB, Ma G, et al. (2002). Dicaffeoyltartaric Acid Analogues Inhibit Human Immunodeficiency Virus Type 1 (HIV-1) Integrase and HIV-1 Replication at Nontoxic Concentrations. J Med Chem 45: 3669-3683.
  • [19] WHO. Laboratory services in tuberculosis control. Part III. WHO/TB/98.258.
  • [20] Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchision DA, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969; 41: 21-43.
  • [21] Omer B, Krebs S, Omer H, Noor TO. Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn’s disease: a double-blind placebo-controlled study. Phytomedicine 2007; 14: 87-95.
  • [22] Kordali S, Cakir A, Mavi A, Kilic H, Yildirim A. Screening of chemical composition and antifungal and antioxidant activities of the essential oils from three Turkish Artemisia species. J Agric Food Chem 2005; 53: 1408-16.
  • [23] Mubashir Hussain et al. A status review on the pharmacological implications of Artemisia absinthium: A critically endangered plant. Asian Pac J Trop Dis 2017; 7(3): 185-192.
  • [24] EMEA, Community herbal monograph on Artemisia absinthium L. herba. London, UK: European Medicines Agency; 2009. (Online).
  • [25] H. R. Moslemi et al., Antimicrobial Activity of Artemisia absinthium Against Surgical Wounds Infected by Staphylococcus aureus in a Rat Model. Indian J Microbiol (Oct–Dec 2012) 52(4): 601–604.
  • [26] Greger, Harald. (1979). Polyacetylene und Sesamine als chemische Merkmale in der Artemisia absinthium–Gruppe. Planta Medica 1979; 35(1): 84-91. DOI: 10.1055/s-0028-1097189
  • [27] L. P. Christensen, Biological activities of naturally occurring acetylenes and related compounds from higher plants. Rec. Res. Dev. Phytochemistry 2, 227-257 (1998)
  • [28] Konovalov, Dmitry. (2015). Polyacetylene Compounds of Plants of the Asteraceae Family (Review). Pharmaceutical Chemistry Journal 48, 36-53. 10.1007/s11094-014-1159-7
  • [29] Huiqing Zheng, Christopher J Colvin, Benjamin K Johnson, Paul D Kirchhoff, Michael Wilson, Katriana Jorgensen-Muga, Scott D Larsen, Robert B Abramovitch. “Inhibitors of Mycobacterium tuberculosis DosRST signaling and persistence. Nature Chemical Biology, 2016; DOI: 10.1038/nchembio.2259
Document Type
short_communication
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-756038b5-5aff-40d8-95bb-8ce2d76dbf24
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.